

23andMe bankrupt, CEO out
Mar 24, 2025
23andMe files for bankruptcy, leading to the resignation of its CEO, a shocking turn in the biotech sector. Meanwhile, James Hardie Industries makes waves by acquiring AZEK for $8.75 billion. In tech news, a Korean AI chip startup turns down an $800 million offer from Meta, signaling growing confidence in the AI market. The AI boom mirrors the dot-com bubble but with important distinctions, raising questions about market trends. Luxury carmakers now face hurdles due to proposed tariffs, adding to the tension in the stock market.
AI Snips
Chapters
Transcript
Episode notes
23andMe Bankruptcy
- 23andMe, once valued at $6 billion, filed for bankruptcy with a $50 million valuation.
- CEO Ann Wojcicki resigned after exploring strategic alternatives, including privatization attempts.
Reasons for 23andMe's Failure
- Despite promising healthcare revolution with DNA tests, 23andMe never achieved profitability.
- Unsuccessful product development, a data breach, and funding issues contributed to its downfall.
James Hardie Acquires AZEC
- James Hardie Industries will acquire AZEC for $8.75 billion in a cash and stock deal.
- AZEC shareholders will receive $26.45 cash and 1.034 James Hardie shares per AZEC share.